Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Procyon and Biovation enter cancer immunotherapy agreement

Oct. 13, 2000

Antitumor agents patented by Japanese researchers

Oct. 11, 2000

Recent patent covers new inhibitors of specific MMPs

Oct. 11, 2000

Novel target for anticancer therapy and new compounds discovered at Klinge

Oct. 10, 2000

CRL-8256, with potential in cancer chemotherapy, emerges from joint French and Belgian research

Oct. 10, 2000

Coulter's Bexxar assigned priority review status by FDA

Oct. 10, 2000

Myriad reports location of prostate cancer susceptibility gene

Oct. 10, 2000

Clinical trial results for IL-2/SEB combination therapy for melanoma positive

Oct. 10, 2000

Potent topoisomerase inhibitors related to camptothecin described in recent patent

Oct. 6, 2000

Dihydroquinazoline antitumor agents with folate-independent mechanism described by CRC

Oct. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....